You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Nonlinear Computation Tool to Chart Trajectories of Bipolar Disorder
SBC: Biomedical Development Corporation Topic: 103DESCRIPTION provided by applicant Bipolar disorder BD is a complex chronic illness characterized by recurrent often dramatic mood changes Self management of BD is an important component of treatment but is likewise complex and can be fraught with difficulties including misunderstanding of the condition and a lack of self awareness Combined with the nationwide shortage of mental healthcare ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Comprehensive Time-Resolved Molecular Speciation Of Gaseous And Particulate Organic Constituents In The Atmosphere
SBC: AEROSOL DYNAMICS INC Topic: 17dOrganic chemicals comprise the dominant fraction of particulates found in atmospheric aerosols, and the largest proportions of these are secondary products formed in the atmosphere from oxidation of volatile organic compounds. Often these chemical transformations result from complex pathways involving species from different sources. To understand these processes, we need to be able to trace the ...
STTR Phase II 2015 Department of Energy -
Lentiviral Vector for the treatment of Fanconi Anemia
SBC: Rimedion, Inc. Topic: NHLBIDESCRIPTIONprovided by applicantIn this Phase II STTR application Rimedion seeks to commercialize a novel treatment for patients suffering from Fanconi anemia and request funding for a Phase I II clinical trialThe product will utilize a HIVbased lentiviral vector expressin the Fanconi anemia A proteinThe strong scientific support for this approached is strengthened by a successful Phase I STTRThe ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Recyclable Magnetic Co C Hybrid ROMP Reagents Scavengers and Ligands
SBC: MATERIA, INC. Topic: 300DESCRIPTION provided by applicant This Fast Track Small Business Technology Transfer study between Materia Inc in Pasadena CA and the University of Kansas intends to build upon successes of our current Phase II Fast Track STTR grant R GM which ends on March Preliminary results serve as a solid foundation for this Fast Track submission entitled andquot Development of Re ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Automatic Calibration of High-Performance Metrological Instrumentation
SBC: Abeam Technologies Inc. Topic: 04cMetrology is a multi-billion dollar industry that is an indispensable part of science and manufacturing. A variety of techniques including interferometric microscopes, scanning electron microscopes (SEM), X-ray, and atomic force microscopes (AFM) are used in X-ray mirror manufacturing. The performance of any tool directly depends on the ability to characterize and tune it ...
STTR Phase II 2015 Department of Energy -
A Diagnostic for Simultaneous Liquid and Vapor Distribution in Sprays Using Filtered Rayleigh and Mie Scattering
SBC: METROLASER, INCORPORATED Topic: 07dNew automotive engine technologies, such as direct injection with stratified charge combustion, are being explored under programs of the DOE and others that offer significant increases in efficiency and reductions in emissions. Research tools are needed to help determine how best to adequately control the combustion process throughout the engine operating envelope, to optimize combustion efficienc ...
STTR Phase II 2015 Department of Energy -
Development of Nuclear Quality Components Using Metal Additive Manufacturing
SBC: RADIABEAM SYSTEMS, LLC Topic: 19fA major problem with nuclear fission reactors is the welding of components of dissimilar metals, where the filler is usually of an additional metal alloy that is not necessarily the same as the two parts to be joined. Welding of metals will often have a heat affected zone (HAZ) and a thermo- mechanically affected zone (TMAZ), which need to be post-weld heat treated to minimize precipitation or seg ...
STTR Phase II 2015 Department of Energy -
Protein Sequencing Tools for Biological Therapeutics
SBC: PROTEIN METRICS INC Topic: 400DESCRIPTION provided by applicant Mass spectrometry has become a method of choice for identifying and characterizing small quantities of proteins in complex mixtures However the ability to perform the identification in a high throughput fashion has depended on the availability of high quality protein sequence databases This means that proteins from organisms with unsequenced or poorly sequen ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
AFM based nanoscale IR Spectroscopy (AFM-IR) as a characterization platform for P
SBC: Anasys Instruments Corp. Topic: 300DESCRIPTION provided by applicant Anasys Instruments and Prof Lynne Taylor of Purdue propose to develop nanoscale chemical characterization capabilities for drug formulation research This project will build on successful Phase I research demonstrating feasibility of atomic force microscope based infrared spectroscopy AFM IR in pharmaceutical applications This Phase II research will advance ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t
SBC: AADI, LLC Topic: 102DESCRIPTION provided by applicant In it is estimated that there will be new bladder cancer cases in the United States resulting in deaths Most cases present with nonmuscle invasive bladder cancer NMIBC Intravesical bacillus Calmette Guerin BCG which elicits a nonspecific local immune response is considered the standard first line treatment However ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health